SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049144
Filing Date
2024-04-26
Accepted
2024-04-26 16:15:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ubx-2024_defa14a.htm DEFA14A 14603
2 GRAPHIC img52209381_0.jpg GRAPHIC 212202
3 GRAPHIC img52209381_1.jpg GRAPHIC 150907
  Complete submission text file 0000950170-24-049144.txt   516091
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38470 | Film No.: 24883938
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)